Investors/Analysts meet

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 22 September 2026 Corporate relationship Department, National Stock Exchange of India, Limited BSE Limited, Exchange Plaza, 5th Floor, 1st Floor, Rotunda Building Plot No. C/1, G Block, Bandra-Kurla Complex, P.J Towers Dalal Street, Fort, Bandra (E), Mumbai 400001 Mumbai 400051 Stock Code: BSE – 530549 / NSE – SHILPAMED Dear Sir/Ma’am, SUB: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Intimation for Participation in Investor Conference. Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, as amended from time to time (“Listing Regulations”), we wish to inform you that the official(s) of the Company will be meeting certain Investors/Analysts (Participants) as per the schedule below: Date Event Location Type of Meeting Meeting Format 28 September 2026 Nuvama – Emerging India Mumbai In Person 1x1 and Group CEO Forum Meetings During the Meeting, no Unpublished Price Sensitive Information (UPSI) will be shared. Kindly note that above schedule is subject to change by the Organizers / the Investor / the Company. This is for information and records. For SHILPA MEDICARE LIMITED Ritu Tiwary Company Secretary & Compliance Officer